Sign in
Explore the registryTrack Sacituzumab govitecan combined with toripalimab's trials

A Multicenter, Prospective, Cohort Study of Trop-2 ADC Combination Therapy for Advanced Triple-negative Breast Cancer

Sacituzumab Govitecan combined with ToripalimabOngoingRecruitingPhase 2Open NCT06878625 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…